Weng Xiao-Gang, Li Yu-Jie, Chen Ying, Yang Qing, Wang Ya-Jie, Li Qi, Cai Wei-Yan, Zhu Xiao-Xin
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi. 2018 Sep;43(18):3782-3786. doi: 10.19540/j.cnki.cjcmm.20180522.001.
This article proposes a new thought on the study of "main effect" of traditional Chinese medicine (TCM) formulae. The blood concentrations of the pharmacodynamic substances of Chinese material medica(CMM)are usually very low, with lower toxic and side effects than western medicine. Therefore, according to a recent hypothesis of additive effect of multiple components for a single target, local targets in multi-component multi-target synergistic effect network of TCM may have the additive effect of similar components. Studies on the disposition of CMM showed that a constituent could bebio-transformed to many metabolites; these compounds with a similar structure are likely to have the same pharmacological effects on the same target, which could provide experimental evidences for the hypothesis of "additive effect". The authors of this article further believe that additive effect of TCM multi-components only comes up under a limited conditions/concentration. Because of the complexity of TCM-organism system, the complex effect of multicomponent addition and competition/antagonism is more likely to appear in single targets of drug effect. This complex effect may be the key to impact the synergistic effect of TCM multi-targets. In theory, choose and create a single target additive effect could realize the scientific compatibility of TCM and improve the curative effect and attenuate toxicity. According to the clinical demand and under the guidance of the above thought, we proposed the "main effect" of TCM formulae. Because traditional Chinese medicine (compounds) have diverse and complex effects, how to better study TCM formulae compatibility mechanism and improve the curative effect? Efforts shall be made to select one or several effects relating to clinical specific syndromes from the complex and diverse effects of TCM as the "main effect". The "main effect" of TCM formulae is the macroscopic manifestation of the synergistic effect of multi-component/multi-target. The study of the Formulae "main effect" can contain at least two aspects: one is the study of pharmacokinetic application of TCM formulae, and another is the study for pharmacodynamics effect. In the study of main effect, there are two main elements. First, which drug targets are directly related to the main effect? This requires identifying the target network. Second, which drug components positively or negatively control the single target of the target network? And what change in single target effect as well as the multi-target synergistic effect will be caused by the regulatory component concentration or the change in number? These two elements is the key to elucidate the mechanism of compound action and compatibility mechanism of Chinese herbal compound formulae. Through the study of the main effect, the clinical curative effect and the mechanism of the TCM formulae shall be improved.
本文提出了一种关于中药方剂“主效应”研究的新思路。中药药效物质的血药浓度通常很低,且毒副作用比西药小。因此,根据最近提出的单一靶点多成分相加效应假说,中药多成分多靶点协同效应网络中的局部靶点可能存在相似成分的相加效应。对中药体内过程的研究表明,一种成分可生物转化为多种代谢产物;这些结构相似的化合物可能对同一靶点具有相同的药理作用,这可为“相加效应”假说提供实验证据。本文作者进一步认为,中药多成分的相加效应仅在有限的条件/浓度下出现。由于中药-机体系统的复杂性,多成分相加与竞争/拮抗的复合效应更易出现在药物效应的单一靶点上。这种复合效应可能是影响中药多靶点协同效应的关键。理论上,选择并建立单一靶点相加效应可实现中药的科学配伍,提高疗效并降低毒性。根据临床需求并在上述思路的指导下,我们提出了中药方剂的“主效应”。由于中药(复方)作用多样而复杂,如何更好地研究中药方剂配伍机制并提高疗效?应努力从中药复杂多样的作用中选取与临床特定证候相关的一种或几种作用作为“主效应”。中药方剂的“主效应”是多成分/多靶点协同效应的宏观体现。方剂“主效应”的研究至少可包含两个方面:一是中药方剂药代动力学应用的研究,二是药效学效应的研究。在主效应研究中,有两个主要要素。其一,哪些药物靶点与主效应直接相关?这需要确定靶点网络。其二,哪些药物成分正向或负向调控靶点网络的单一靶点?调节成分浓度或数量变化会引起单一靶点效应以及多靶点协同效应发生何种变化?这两个要素是阐明中药复方作用机制及配伍机制的关键。通过主效应研究,应提高中药方剂的临床疗效及作用机制。